Efficacy and safety of tacrolimus‐based treatment for nephrotic idiopathic membranous nephropathy in young adults: A retrospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of tacrolimus‐based treatment for nephrotic idiopathic membranous nephropathy in young adults: A retrospective study

Published:2019-06-21 Issue:10 Volume:35 Page:633-639
ISSN:1607-551X
Container-title:The Kaohsiung Journal of Medical Sciences
language:en
Short-container-title:The Kaohsiung Journal of Medical Sciences

Author:

Zhang Xiao‐Juan¹²^ORCID,Ji Cheng‐Fa³,Yuan Jiang‐Zi⁴,Wang Lei²,Zhang Jing³,Fang Wei⁴,Bai Dong‐Fang²,Hu Zhao¹

Affiliation:

1. Department of NephrologyQi Lu Hospital of Shandong University Jinan Shandong China

2. Department of NephrologyTaian City Central Hospital Taian Shandong China

3. Shandong New Time Pharmaceutical Co., LTD.Lunan Pharmaceutical Group Co., Ltd. Linyi Shandong China

4. Department of NephrologyRenJi Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/kjm2.12098

Reference22 articles.

1. Chapter 7: Idiopathic membranous nephropathy

2. Idiopathic Membranous Nephropathy: Outline and Rationale of a Treatment Strategy

3. Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy

4. Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of rituximab, tacrolimus and cyclophosphamide in the treatment of idiopathic membranous nephropathy and its influencing factors: Retrospective cohort study;2024-04-25

2. Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study;International Urology and Nephrology;2024-04-20

3. Membranous nephropathy: Mechanistic insights and therapeutic perspectives;International Immunopharmacology;2023-07

4. Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients;BMC Nephrology;2022-09-07

5. Efficacy and safety of tacrolimus monotherapy versus tacrolimus-corticosteroid combination therapy for idiopathic membranous nephropathy;Medicine;2021-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3